Lv11
100 积分 2023-08-31 加入
Menstrual Irregularities and Amenorrhea in Thyroid Eye Disease Patients Treated With Teprotumumab
2小时前
已完结
Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series
1个月前
已关闭
Quality of life in Graves’ ophthalmopathy
1个月前
已完结
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL
1个月前
已完结
Modification of the Classification of the Eye Changes of Graves' Disease
1个月前
已完结
Teprotumumab-Associated Deafness: A Pharmacovigilance Analysis
1个月前
已关闭
Systemic Adverse Events Associated with Teprotumumab Use: A Population-Based Pharmacovigilance Study
1个月前
已完结
Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy
1个月前
已完结
Hearing abnormalities in patients treated with teprotumumab
1个月前
已完结
Safety of long-term antithyroid drug treatment? A systematic review
1个月前
已完结
皖公网安备34019202002308
